CAR-TCR Summit Boston 2021

Conference themes
With 2 CAR-T therapies striving for global approval, and a 3rd contender from Bristol-Myers Squibb closing in on the finish line of the race to market, the CAR-TCR field continues to boom with excitement as the competition begins to heat back up.

It is well known that the current approved therapies have encountered some difficulties, specifically around their pricing and uptake in hospitals due to expensive manufacturing processes.

Professional congress organizer (PCO)
Hanson Wade

Notes
Brochure: https://go.evvnt.com/637810-3?pid=4832

Speakers: Sanjay Srivastava, Accenture, Robin Goodreau, Access Biologicals, Erica Elefant, Adaptimmune, Stewart Abbott, Adicet Bio, Paul Rennert, Aleta Biotherapeutics, and more.

https://go.evvnt.com/637810-2?pid=4832

Ms. Georgina FitzGerald